Back to Journals » Drug Design, Development and Therapy » Volume 13

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Total article views   HTML views PDF downloads Totals
8,826 Dovepress* 7,198+ 1,609 8,807
PubMed Central* 1,628 456 2,084
Totals 8,826 2,065 10,891
*Since 11 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 3 7

View citations on PubMed Central and Google Scholar